Aegerion Pharmaceuticals appoints officer

Aegerion Pharmaceuticals Inc. (Nasdaq: AEGR) appointed Remi A. Menes to the position of chief commercial officer. The stock price climbed 51 cents to close at $2.37.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.